One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals Post author: Post published:November 16, 2023 Post category:uncategorized The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients. You Might Also Like AI model as diabetes early warning system when driving February 8, 2024 IBD patients with family cancer history more likely to develop colorectal cancer September 3, 2026 Microplastics pose potential risks to bone health September 18, 2025